Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma

Clinical trial NCT02909777 · COMPLETED

Trial details

NCT number: NCT02909777
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma Neuroblastoma Brain Tumor Solid Tumor

Start date: 2016-10-01
Primary completion: 2025-12-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.